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ABSTRAK (BAHASA MELAYU) 
 
Topik: Penggredan Glioma Supratentorial Menggunakan Pengimejan 
Resonans Magnetik (MR) Difusi Tensor (DTI) 
 
Latar Belakang dan Tujuan: Gliomas merupakan tumor otak utama yang 
paling biasa yang kebanyakannya terletak di kawasan supratentorial pada 
orang dewasa. Mereka dikelaskan kepada gred rendah (gred I dan II) dan 
gred tinggi (gred III dan IV) berdasarkan klasifikasi WHO. Pengimejan MR 
konvensional adalah penting untuk mencirikan morfologi tumor tetapi 
kekurangan ketepatan dalam menentukan gred tumor. Teknik canggih MR 
seperti DTI telah muncul sejak beberapa dekad lalu sebagai kaedah 
tambahan untuk menilai secara mendalam tumor otak di peringkat 
mikrostruktur dan fisiologi. 
 
Penggredan tepat glioma adalah penting untuk menentukan cara rawatan dan 
urutan pengurusan untuk pesakit. Oleh itu, kajian ini bertujuan untuk secara 
retrospektif menentukan sama ada nilai-nilai FA atau ADC pada 3-Tesla MR 
DTI jauh berbeza antara gred rendah dan gred tinggi glioma supratentorial. 
Nilai-nilai FA dan ADC antara glioma dan hemisfera serebrum yang normal 
juga dibandingkan. 
 
Metodologi: Enam belas pesakit yang berumur 18 tahun dan ke atas yang 
baru didiagnosa glioma supratentorial dengan keputusan histopatologi 
dimasukkan dalam kajian. MRI mereka dengan turutan DTI diambil dari PACS 
  xiii 
ke dalam program “MR extended workspace” untuk analisis data. Data DTI 
telah didaftar bersama dengan imej T1 selepas administrasi gadolinium. 
Empat kawasan kajian (ROI) dilukis pada margin depan, belakang, sisi dan 
medial tumor. ROI juga diletakkan di sumsum otak putih kontralateral lobus 
yang bertentangan. Perbandingan nilai-nilai FA dan ADC antara glioma gred 
rendah dan gred tinggi, dan di antara glioma dengan sumsum otak putih 
kontralateral telah dilakukan dengan menggunakan ujian Mann-Whitney U 
dan ujian Wilcoxon signed ranks. 
 
Keputusan: Terdapat perbezaan yang signifikan secara statistik antara nilai 
FA glioma gred rendah dan gred tinggi, dan di antara nilai-nilai FA dan ADC 
daripada glioma dan sumsum otak putih kontralateral (p <0.05). Tiada 
perbezaan yang signifikan secara statistik antara ADC glioma gred rendah 
dan gred tinggi (p = 0.129). 
 
Kesimpulan: Nilai FA dijana daripada DTI boleh digunakan untuk 
penggredan glioma. Nilai ADC daripada glioma gred rendah adalah lebih 
tinggi daripada glioma gred tinggi tetapi tidak signifikan secara statistik. 
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ABSTRACT (ENGLISH) 
 
Topic: Grading Of Supratentorial Gliomas Using MR Diffusion Tensor 
Imaging 
 
Background and Purpose: Gliomas, being the most common primary brain 
tumours are usually located at the supratentorial regions in adults. They are 
classified into low grade (grade I and II) and high grade (grade III and IV) 
based on WHO classification. Conventional MR imaging is essential to 
characterise the tumour morphology but lack accuracy in determining the 
grade of tumours. Advanced MRI technique such as DTI has emerged over 
the past decades as an additional method to further evaluate the brain 
tumours at the microstructural and physiological levels. 
 
Accurate grading of gliomas is important to determine the mode of treatment 
and sequences of management for patients. Therefore, this study aims at 
retrospectively determines whether FA or ADC values at 3-Tesla MR DTI are 
significantly different between low grade and high grade supratentorial 
gliomas. FA and ADC values between the gliomas and normal cerebral 
hemisphere are also being compared. 
 
Methodology: Sixteen patients aged 18 years old and above with newly 
diagnosed supratentorial gliomas with histopathological results were included. 
Their MRI with DTI sequence were retrieved from PACS into extended MR 
workspace for data analysis. DTI data was co-registered with post-gadolinium 
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T1 weighted images. Four ROIs were drawn at the anterior, posterior, lateral 
and medial margins of tumours. ROIs were also placed at the contralateral 
NAWM of the opposite lobe. Comparison of FA and ADC values between low 
grade and high grade gliomas, and between gliomas with contralateral NAWM 
was performed using Mann-Whitney U test and Wilcoxon signed ranks test 
respectively. 
 
Results: There was significant difference between FA of low grade and high 
gliomas, and between FA and ADC of gliomas and contralateral NAWM (p < 
0.05). No statistical significant difference was found between the ADC of low 
grade and high grade gliomas (p = 0.129). 
 
Conclusion: FA values generated from DTI can be used to grade gliomas. 
ADC values of low grade gliomas are higher than that of high grade gliomas 
but are not statistical significantly different. 
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CHAPTER 1 INTRODUCTION 
 
Primary brain tumours in adults are commonly found in the 
supratentorial region. Whether they are extra-axial meningiomas or intra-axial 
gliomas, they are graded into low grade (grade I or II) or high grade (grade III 
or IV) based on World Health Organisation (WHO) classification.  
 
Magnetic resonance imaging (MRI) over the years has become the 
imaging of choice for evaluation and characterisation of brain tumours, due to 
its superiority in exhibiting the soft tissue contrast as compared to computed 
tomography (CT). Establishing the diagnosis of brain tumours and the 
accurate grading is crucial, as it would largely affect the decision-making with 
regards to the treatment, whether patient can be managed conservatively or 
whether surgical removal is required (Essig et al., 2012). 
 
Conventional MR imaging with gadolinium-based contrast agents is 
helpful in providing information regarding the tumour enhancement pattern, 
perilesional oedema, haemorrhage, necrosis and mass effect. However, 
several studies have shown that this information may be inaccurate in 
determining the grading of the tumours despite optimisation of the sequences 
and protocols (Law et al., 2003). 
 
  2 
With the advancement of technology over the recent years, advanced 
MR imaging techniques such as diffusion tensor imaging (DTI) has emerged 
as a method to better assess and characterise the brain tumours. 
 
Diffusion tensor Imaging (DTI) is a relatively new imaging technique, 
which relies on the ordered anisotropy diffusion of water along the white 
matter tracts. Water molecules show microscopic random (Brownian) 
translational motion, thus the molecular mobility of water is the same in all 
direction. This is termed ‘diffusion isotropy’. However in vivo, complex 
microstructures in tissue such as white matter tracts, capillary vessels and cell 
membranes act as barriers, causing directionality of water diffusion to arise in 
three-dimensional space. This directional variation is called ‘diffusion 
anisotropy’. DTI has the ability to quantitatively acquire the magnitude and 
directionality of water diffusion along a vector in a three-dimensional space. 
Several parameters have been used to quantify the anisotropy, the common 
ones being fractional anisotropy (FA) and apparent diffusion coefficient (ADC) 
(Beppu et al., 2003). 
 
Brain tumours cause disturbance to the architecture and water content 
in the brain tissue. Such disturbance in the cell structure will change the 
magnitude and directionality of water diffusion, of which DTI is able to capture 
and quantify. This may potentially more accurately assess the brain tumours 
than just conventional MRI. Even though previous studies on MR 
spectroscopy, conventional diffusion-weighted imaging and perfusion MRI 
have suggested that these functional studies are helpful in glioma grading, 
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DTI for glioma grading remains an area still fresh for more exploration and 
research (Lee et al., 2008). 
 
The aim of this study is to therefore retrospectively determine whether 
FA or ADC value at 3-Tesla MR DTI is significantly different between low 
grade and high grade supratentorial gliomas and its usefulness for glioma 
grading. Apart from that, the FA and ADC values between the gliomas and 
normal cerebral hemisphere are also being evaluated. 
 
The rationale of this study is that accurate grading of the gliomas is 
essential in determining the mode of treatment and sequences of 
management for the patients. Even though conventional MRI can provide the 
morphological and anatomical features, it cannot reliably grade the tumours, 
as the features between the low grade and high grade gliomas can overlap. 
Thus, by adding the DTI sequence and evaluating the parameters, which 
include FA and ADC, it is aimed to determine a reproducible way of drawing 
the region of interest (ROI) to differentiate the low grade and high grade 
gliomas. 
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CHAPTER 2 LITERATURE REVIEW 
 
Brain tumours compared to other tumours are relatively uncommon, 
accounting for 2.7% and 1.7% respectively of all cancers in males and 
females in Peninsular Malaysia (Lim et al., 2008). Having said that, they are 
the most debilitating tumours due to their location in the brain. Even benign 
brain tumours can cause significant functional impairment or even death. 
Approximately half of the patients with brain tumours still survive one year 
after the diagnosis (Lee et al., 2014a). With the recent advancement in 
neuroimaging technology, the management of patients with brain tumours 
have improved owing to early accurate diagnosis and localization. 
 
2.1 Glioma 
 
The incidence of central nervous system tumours in the United States 
in 2000 was 6.7 per 100,000 persons and gliomas account for approximately 
51% of all cases (Hess et al., 2004). This is much higher as compared to the 
incidence in HUSM, which is 35% of all intracranial tumours. Glioma incidence 
is slightly higher among males, accounting for 57.4% of all gliomas (Yusof, 
1998). The incidence has been on the increasing trend over the years, due to 
the fact that development of diagnostic imaging is rampant in the past decade. 
Others have attributed this to the changes in classification and coding system 
(Vovoras et al., 2014). 
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Glioma arises from abnormal proliferation of glial cells. The nervous 
system is made up mainly by two groups of cells, namely neurons and glial 
cells. Glial cells are non-neuronal cells that surround neurons and function by 
formation of myelin sheaths around axon. They also help to maintain the 
optimal concentrations of ions and neurotransmitters in the neuronal 
environment. In response to injury, they are responsible for the regulators for 
neuronal repair. Glial cells are in fact a broad category of cells made up of 
many sub-types (Jessen, 2004). Thus, gliomas can be classified based on 
their cell types and are subdivided into astrocytomas, oligodendrogliomas, 
ependymomas, brainstem gliomas, optic nerve gliomas and mixed gliomas. 
More than 75% of patients diagnosed with gliomas consist of astrocytomas. 
Astrocytomas are graded using standard WHO scheme that depends on 
assessment of nuclear atypia, mitotic activity, cellularity, vascular proliferation 
and necrosis. They are classified into four grades, namely pilocystic 
astrocytoma (grade I), diffuse astrocytoma (grade II), anaplastic astrocytoma 
(grade III) and glioblastoma multiforme (GBM) (grade IV). 
 
The loss of tumour suppressor genes and activation of oncogenes are 
two established fundamental mechanisms that cause cancer in humans, 
including gliomas. In particular, glioblastoma multiforme has loss of genetic 
materials on chromosome 10 and epidermal growth factor receptor (EGFR) 
gene amplification (Andreas von Deimling et al., 1992). Gliomas may be 
associated with certain inherited syndromes such nuerofibromatosis type 1 
and 2, Turcot’s syndrome and Li-Fraumeni syndrome, but the incidence is 
very rare (Malmer et al., 2001). The only most established and proven 
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environmental risk factor to cause increased risk of gliomas is therapeutic 
ionising radiation. Particularly in children who have been treated with 
therapeutic irradiation for acute lymphoblastic leukaemia have significant 
increased risk of developing gliomas and primitive neuroectodermal tumour 
(PNET) within 10 years after therapy. It was found that the mutations of TP53 
occurred among these patients, causing the formation of low grade gliomas 
and glioblastomas (Ohgaki and Kleihues, 2005). Association with head injury, 
food containing N-nitroso compounds, occupational risk, exposure to 
electromagnetic fields and usage of mobile telephones have no strong 
evidence of increased risk of gliomas. On the other hand, association has 
been found between immunologic factors and gliomas, for which patients with 
atopy have reduced risk of gliomas and those who have glioblastomas but 
with elevated IgE survive longer than those with normal levels (Wen and 
Kesari, 2008). 
 
2.2 Clinical Presentation of Glioma 
 
Patients with gliomas can virtually present with any neurological 
symptoms, depending on the location of the tumour rather than the 
histological type of the tumours (Schneider et al., 2010). Having said that, the 
commonest presentation is headache in up to 50% of patients, with non-
specific pain pattern. Features such as progressive severity, new-onset 
headache and unilateral localisation in patients more than 50 years old are 
more suggestive of tumour-associated headache than just a benign headache 
(Omuro and DeAngelis, 2013). 
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Other clinical presentation would be partial or generalised seizures, in 
which it is frequent when the tumour is located at the cortex and is the slow 
growing type. Patients may also present with features of raised intracranial 
pressure, which include progressive headache, nausea, vomiting, drowsiness, 
visual disturbances (papilloedema on fundoscopy and diplopia secondary to 
abducens nerve palsy) and hydrocephalus due to cerebrospinal fluid 
circulation obstruction. These usually occur in rapidly growing tumours at the 
silent areas of the brain (right frontal and temporal lobes), causing vasogenic 
oedema. Progressive neurological deficit is another possible clinical 
presentation, and it helps in determining the possible tumour site. 
Supratentorial tumours will cause motor or sensory deficits, hemianopia, 
aphasia or a combination of all these, while posterior fossa tumours will have 
symptoms and signs of cranial nerve palsies, cerebellar dysfunction and long-
tract signs. Finally, patients may have variable severity of cognitive 
dysfunction, especially those with tumours at frontal lobes, meningeal spread 
of the tumour and diffuse brain infiltration (Behin et al., 2003). 
 
Due to the variable presentations, clinical features are unreliable to 
determine low grade gliomas from high grade gliomas and other intracranial 
space occupying lesions. Thus, it is essential to perform neuroimaging to 
further evaluate these tumours. 
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2.3 Imaging of Glioma 
 
Radiological imaging techniques have been advancing by leaps and 
bound over the recent years and diagnosis of the brain tumours has improved 
tremendously with the new imaging techniques. CT and MR are the two main 
modalities that play an essential role in neuroimaging (Zelenak et al., 2013). 
They are considered the primary non-invasive option to evaluate patient 
suspicious of brain tumours. 
 
CT of the brain is acknowledged as an initial screening method for the 
patient suspicious of brain tumour. It is more easily available at most of the 
hospitals as compared to the MRI machine and is less time-consuming. Thus, 
it is especially useful in emergency setting when patient is not so stable and 
uncooperative, where a MR imaging protocol is impractical on the day of 
presentation (Essig et al., 2012). CT scan can be useful to rule out other 
pathologies that may present similarly as brain tumours, such as cerebral 
abscess, which warrant urgent loading of antibiotics and early surgical 
drainage if indicated. While CT scan has lower resolution than MRI, it is better 
in depicting calcification, bone abnormalities and hyperacute bleed. The 
setbacks of CT scan include possibility of missing some small tumours due to 
lower soft tissue contrast, moderate specificity in determining the types of 
tumours and exposure to ionising radiation. 
 
The basic CT examination of brain tumours encompasses standard 
non-contrasted and contrast enhanced imaging (Zelenak et al., 2013). 
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Calcification within tumours can be evaluated on the non-contrasted images. 
Pattern and degree of enhancement on the other hand may help to arrive to a 
possible diagnosis. Other important features to note include mass effect that 
causes hydrocephalus and brain herniation, in which emergency 
extraventricular drainage and decompression are needed prior to a definitive 
surgery later. 
 
MR imaging is a better option for further characterisation of cerebral 
gliomas. Conventional MR imaging is far superior than the CT scan due to 
higher sensitivity, higher soft tissue contrast to portray the anatomical 
conditions of the brain tissue, better depiction of the extent of tumours and the 
ability to have multiplanar acquisition (Schneider et al., 2010). MR scanner 
also produces little or no signal to the cortical bone structures, thus 
eliminating artefact. In contrast to CT scan, the posterior fossa and base of 
skull are difficult to be evaluated due to the beam hardening artefact produced 
by the bone (Oot et al., 1988). 
 
The basic MR imaging protocol for the demonstration of the cerebral 
tumour include T2- and T1-weighted native and contrasted sequences, and 
fluid-attenuated inversion recovery (FLAIR) sequences. Certain cases may 
need to include T2-weighted gradient echo sequence (GRE) to show 
calcification and blood. In general brain tumours are hypointense or isointense 
on T1-weighted sequence and hyperintense or isointense on T2-weighted 
imaging. The tumour’s signal is altered based on the intralesional proportion 
of the individual components, which include solid, cystic, necrotic or 
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haemorrhagic components, fatty tissue, or even increased proportion of 
protein in the cystic part (Zelenak et al., 2013). 
 
In certain cases, the brain tumours can be hard to visualise in non-
contrast imaging, thus the administration of a paramagnetic contrast medium 
is advocated. Intravenous contrast medium is administered in order to reveal 
the full extent of the tumour and to differentiate the tumour tissue from 
perilesional oedema, between viable and non-viable tumour tissue, as well as 
detection of any small satellite lesions (Schneider et al., 2010). 
 
2.4 Advanced MRI Techniques 
 
Several earlier studies had shown that grading of gliomas with 
conventional MR imaging based on the tumour features have been erroneous, 
with sensitivity in identifying high-grade gliomas between 55.1% to 83.3% 
(Law et al., 2003). Tumour features include crossing of the midline, oedema, 
heterogeneity, haemorrhage, border definition, cyst or necrosis and mass 
effect. Two of these features are statistically significant predictors of tumour 
grading. Mass effect and necrosis tend to be more predictive of high-grade 
gliomas while other features are not statistically significant between both low- 
and high-grade gliomas (Dean et al., 1990). Another study revealed that there 
is high false-positive rate of 50% to diagnose low grade astrocytomas based 
on conventional MR imaging alone (Kondziolka et al., 1993). 
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With all these limitations, modern advanced MR imaging techniques 
have been evolved by leaps and bounds over the past decade. Neuro-
diagnostic imaging is no longer confined to the assessment of pathological-
anatomical condition, but also expands to evaluate the changes at 
microvascular integrity, haemodynamic characteristics, and the freedom of 
water molecule movement. In addition to that, the metabolic and biochemical 
changes are also being examined (Al-Okaili et al., 2006). Incorporating 
advanced MR imaging techniques, such as spectroscopy (MRS), diffusion 
weighted imaging (DWI), diffusion tensor imaging (DTI) and tractography, 
perfusion weighted imaging (PWI) and functional imaging (fMRI), will improve 
diagnostic, prognostic and therapeutic assessments. Not only can MR 
imaging help to evaluate structural abnormality and identify tumour-related 
complications, it also can aid in grading gliomas, in guiding stereostatic 
biopsies, differentiate types of tumours from primary to metastatic tumours, 
monitor treatment response and distinguish tumour recurrence from treatment 
necrosis, and eliminate tumour-mimicking lesions such as stroke and 
tumefactive-demyelinating lesions (Young and Knopp, 2006). 
 
MR spectroscopy (MRS) is one of the advanced MR imaging technique 
that has moved from just clinical research level to become part of the routine 
clinical practice. MRS evaluates the biochemical and metabolic changes of 
the brain tumours and their surrounding tissues at the cellular level. Thus, it 
can discover the pathological process before the conventional method. 
Metabolic signals are obtained and expressed as a spectrum in which position 
of a specific metabolite is placed on the horizontal axis in chemical shifts 
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specified in parts per million (ppm) and the vertical axis represents the 
intensity of its signal (Zelenak et al., 2013). Typical metabolites being 
evaluated are choline (Cho), creatine (Cr), N-acetylaspartate (NAA), lipid, 
lactate and myo-inositol. NAA are predominantly found in neurons, thus 
reduced in its signal in tumours because the normal neurons have been 
destroyed by the neoplastic process. Choline on the other hand is elevated in 
neoplasm due to the increased cell membrane turnover caused by tumour 
growth. Elevated lactate signal is contributed by the relative anaerobic 
environment of many neoplasms and the incomplete breakdown of glucose. 
Despite that, there is no clear cut off metabolic signal ratios that can 
distinguish between neoplastic and non-neoplastic conditions. Prior 
publications on MRS showed that Cho/NAA ratio of greater than 1 is an 
indicator of neoplastic process with the sensitivity of 79% and specificity of 
77%. Cho/NAA cut off ratio of 2.2 was reliable in distinguishing high grade 
tumours from low grade tumours and non-neoplastic conditions. In the area of 
grading primary cerebral tumours, high grade tumours are prone to have 
elevated lipid signal while low grade tumours have high myoinositol peak (Al-
Okaili et al., 2006). A later study of using MRS in tumour grading revealed that 
the choline/NAA ratios are higher and the NAA/creatine ratios lower in high 
grade gliomas than in low grade gliomas. MRS is also able to determine that 
Cho/NAA and Cho/creatine are higher in high grade gliomas than low grade 
gliomas in the peritumoural hyperintensity, which is either vasogenic oedema 
or infiltrative tumour or both in conventional MR imaging. Thus, MRS helps in 
delineating the tumour extension better than the conventional MRI (Leung et 
al., 2014). 
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Diffusion-weighted imaging (DWI) employs the theory of diffusion that 
water molecules move in constant, random Brownian motion in all directions. 
Biological tissues are isotropic when the diffusion is the same in all directions 
and anisotropic if the diffusion is restricted in one direction, such as by cell 
membrane. In the brain, cerebrospinal fluid is an isotropic field. Grey matter is 
more limited than fluid but its diffusion is still in all directions and is therefore 
isotropic as well. White matter on the other hand is anisotropic because the 
diffusion progresses with greater intensity in the direction within axons 
(Zelenak et al., 2013). 
 
DWI is acquired using motion-sensitive sequence; usually echo planar 
imaging (EPI) in three orthogonal directions, for the movements of protons in 
water. A proton will spin at the same rate under the same magnetic field, but 
when a pulsed gradient is applied, it will spin at different rate based on the 
strength, duration and direction of the gradient. The proton will then refocus 
when a second pulse gradient is being applied. If the protons have not moved 
the refocusing will be complete and the signal remains unchanged, while if the 
protons have moved between these two pulses, loss of signal that is 
dependant on the degree of diffusion weighting (referred to as b-value) and 
diffusion coefficient occurs. As the signal change with DWI is also dependant 
on the underlying T2-weighted signal, it cannot be used to quantify diffusion 
processes alone. Thus, the gradient of the signal intensity is plotted based on 
different b-values. This measure of all motional processes is called the 
apparent diffusion coefficient (ADC), which often mirrors the changes in DWI 
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(Price, 2007). Below is the example of DWI and ADC maps acquired in a 
patient with grade III anaplastic astrocytoma at the left frontal lobe (Figure 
2.1). 
 
  
Figure 2.1 DWI (a) and ADC (b) maps of a patient with left frontal 
anaplastic astrocytoma showing the reciprocal signal 
intensity of both maps.  
 
 
 
 
 
 
 
 
 
a b 
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The application of DWI in neuroimaging is vast, which encompasses 
the evaluation of stroke, cerebral infections, cerebral tumours, traumatic 
changes and demyelinating lesions. Specifically in the areas of cerebral 
tumours evaluation, previous studies have shown that ADC maps can help to 
differentiate tumour, oedema, cysts and necrosis, thus being a powerful tool 
to characterise cerebral tumours (Castillo et al., 2001). In one study regarding 
the role of DWI in patients with brain tumours, the authors found that ADC 
values cannot reliably differentiate types of tumours, but lower ADC values 
indicate high grade gliomas while higher ADC values represents low grade 
astrocytoma. ADC values in this study correlated well with the tumour 
cellularity in astrocytomas and meningiomas (Kono et al., 2001). However, a 
later study particularly on ADC of human brain tumours at MR imaging, the 
authors concluded that ADC is able to differentiate some of the brain tumours 
in humans. They discovered a good inverse correlation between ADC and 
WHO grade II to IV astrocytic tumours, whereby the accuracy to differentiate 
grade II from grade III & IV is 91.3% and the accuracy to differentiate grade III 
from grade IV is 82.4% (Yamasaki et al., 2005). 
 
Another advanced MR imaging that also utilises the diffusion of water 
is diffusion tensor imaging (DTI), which is a technique that has been 
developed more recently than the DWI. The difference between these two 
techniques is that DTI will sample the water movement in minimally six non-
collinear directions, as compared to DWI which acquire the movement in three 
directions only (Provenzale et al., 2006). DTI is sensitive to anisotropic or 
directionally dependent diffusion, thus providing unique information on three-
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dimension (3D) diffusivity, characterised by three eigenvectors (direction) and 
three eigenvalues (magnitude). The term “tensor” is a mathematic construct 
derived from physics and engineering to describe tension forces in solid 
bodies with an order of 3D vectors. Tensor is formed from a matrix of 
numbers adopted from diffusion measurements in at least six independent 
diffusion-encoding directions to calculate orientation-dependent diffusion in all 
spatial directions for each voxel in DTI. In human brains, the anisotropic 
diffusion is mainly contributed by myelin and axons. The unique microscopic 
diffusion barrier created by the lipid bilayer of myelin sheath results in various 
degrees of diffusion along different planes. Despite that, this alone cannot be 
responsible entirely for the anisotropic diffusion as non-myelinated nerves 
also show significant diffusion anisotropy. Therefore, the axons and their 
subcomponents such as microfilaments, neurofilaments, microtubules and 
membranes also influence the diffusion anisotropy greatly. Despite the 
biologic basis of diffusion anisotropy is yet to be completely understood, this 
unique features caused by the axonal bundles and myelin sheath enable the 
measurement and fibre orientation tracking, especially in the large white 
matter tracts, thus helping tremendously in neuroimaging and neurosurgery 
(Cha, 2006). 
 
The DTI data needs to be extracted and be analysed in three ways to 
provide information on tissue microstructure and architecture for each voxel. 
First is the mean diffusivity, which characterises the overall mean-squared 
displacement of molecules and presence of restriction to diffusion. Secondly, 
the degree of anisotropy, which describes the amount of molecular 
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displacements vary in space and is related to the oriented structures. Thirdly, 
the main direction of diffusivities that is connected to the orientation in space 
of the structures. Thus, the most common derived DTI parameters are 
fractional anisotropy (FA) and mean diffusivity (MD). Anisotropy is usually 
represented by the FA or alternatively by the relative anisotropy (RA). The FA 
is a measure of the fraction of the magnitude of the diffusion tensor owing to 
anisotropy, while RA is composed by the ratio between the anisotropic and 
isotropic portions of the diffusion tensor. FA ranges from 0 to 1, in which 0 
represents isotropic with zero net direction and 1 denotes maximal anisotropy 
that occurs along the primary eigenvector. MD on the other hand is the mean 
of the three eigenvalues or a directionally averaged measure of the magnitude 
of water diffusion. MD is analogous to ADC and is related to the integrity of 
the brain tissue (Le Bihan et al., 2001). 
 
The most common clinical application of DTI is in the area of 
tractography. Tractography derived from DTI data maps allows visualisation of 
the white matter tracts, thus allowing neurosurgeon to know the topography, 
integrity and degree of involvement of the white matter fibres in pre-operative 
planning. This would help in minimising the functional damage and 
determining the extent of pathologic tissue infiltration in order to minimise 
residual tumour volume. White matter tracts are characterised as displaced 
when they maintain normal anisotropy relative to the corresponding 
contralateral tract but are abnormally located or orientated based on the 
standard colour code. They are considered as oedematous if they maintain 
the normal anisotropy and orientation but with obvious high signal intensity on 
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T2 weighted images. If the white matter tracts have reduced anisotropy yet 
remain visible on the orientation map, they are considered as infiltrated by 
tumour. Lastly, they are termed degenerated when the anisotropy is 
significantly reduced such that no identifiable tracts are seen on the 
orientation maps (Zoccatelli et al., 2013). The below figure is an example of a 
DTI map of a patient with right parietal pilocystic astrocytoma (Figure 2.2). 
 
 
Figure 2.2  DTI map of a patient with right parietal pilocystic 
astrocytoma showing disruption of the normal white matter 
colour code. 
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Apart from that, many studies have been centred upon characterising 
and grading brain tumours using DTI in order to establish more applications of 
DTI. In a study of peritumoural DTI of high grade gliomas and metastatic brain 
tumours, both displayed significant increases in MD and significant decreases 
in FA when compared with normal-appearing white matter (NAWM). The 
peritumoural MD of metastatic brain tumours is also significantly greater than 
that of gliomas, but not the FA values. Thus this concluded that diffusion 
metrics are altered within the vasogenic oedema around the gliomas and 
metastatic brain tumours, reflecting increased extracellular water. And 
peritumoural MD can be used to distinguish high grade gliomas from 
metastatic brain tumours (Lu et al., 2003). 
 
Another study on using DTI for glioma grading at 3-Tesla MRI revealed 
that FA ratios at the non-enhancing regions were not significantly different 
between low and high grade gliomas, but MD ratios were significantly lower in 
high grade gliomas. And in high grade gliomas, the enhancing tumours 
showed lower FA ratios than the non-enhancing tumours. Thus, the author 
concluded that MD values of non-enhancing gliomas are useful for grading 
(Lee et al., 2008). 
 
In a study of measurement of FA using DTI in supratentorial astrocytic 
tumours, the author stated the mean FA values of frontal or occipital lobes 
differed significantly with genu and splenium of corpus callosum, but the 
differences between the frontal lobe and occipital lobe or between the genu 
and splenium were not significant. Mean FA value of frontal lobe was 0.33 ± 
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0.04, occipital lobe 0.32 ± 0.04, genu 0.69 ± 0.04 and splenium 0.72 ± 0.04. 
Regardless of the histological types of the astrocytomas, the mean FA values 
were lower than that of normal appearing white matter. The findings in the 
study suggested the FA value of an astrocytic tumour is influenced by the 
balance between destruction or displacement of normal fibre structure and 
cellularity and/ or vascularity. Thus, measurement of FA value using DTI will 
predict the histological characteristics (Beppu et al., 2003). 
 
A study about the DTI of high grade cerebral gliomas focused on 
differentiating tumour core, oedematous brain and normal-appearing white 
matter using DTI. In this study, it was found that the MD was highest in the 
necrotic tumour core (1825.3 x 10-6 mm2/s), followed by oedematous brain 
(1411.23 x 10-6 mm2/s), enhancing tumour core (1308.67 x 10-6 mm2/s), 
enhancing tumour margin (1229.80 x 10-6 mm2/s) and normal brain (731.53 x 
10-6 mm2/s), out of which MD was significantly different in enhancing tumour 
margins and oedematous brain in all patients. FA on the other hand was 
highest in the normal brain (0.47 ± 0.08), followed by oedematous brain (0.17 
± 0.08), enhancing tumour margin (0.16 ± 0.06), enhancing tumour core (0.13 
± 0.06) and lowest in necrotic tumour core (0.09 ± 0.03). This is however 
significantly different in only seven out of the nine patients (Sinha et al., 2002). 
 
 One of the latest studies in evaluating the FA characteristics of 
cerebral gliomas using DTI used not just mean FA, but also maximum and 
minimum FA values, FA range as well as maximum standard deviation (SD). 
The study revealed that the maximum FA, FA range and maximum SD for 
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grade II tumours were significantly lower than those for grade III and IV 
tumours. A very good correlation of maximum FA to FA range and maximum 
SD were obtained, therefore suggesting that FA range and maximum SD to 
be the added values to findings on conventional imaging in differentiating low 
and high grade gliomas (White et al., 2011). However, the placement of 
region of interest (ROI) for maximum FA and maximum SD can be tedious 
and difficult. 
 
2.5 Histopathological Criteria for Grading of Gliomas 
 
The fourth edition of the World Health Organisation (WHO) of tumours 
of the central nervous system was published in 2007 with several new entities 
being listed. The very first international classification of human tumours was 
initiated through a resolution of the WHO Executive Board in 1956 and the 
World Health Assembly in 1957. The main aim for this was to establish a 
classification and grading of human tumours that is accepted and used 
worldwide. Thus, first edition on histological typing of tumours of the nervous 
system was edited by Zulch and published in 1979. The second edition 
followed due to the advances in immunohistochemistry being introduced into 
diagnostic pathology. The third edition edited by Kleihues and Cavenee and 
published in 2000, incorporated genetic profiles in defining brain tumours. It 
also included epidemiology, clinical signs and symptoms, imaging, prognosis 
and predictive factors (Louis et al., 2007). 
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It was not known whether gliomas originate from mature or 
neuroectodermal stem cells located in the adult brain, but pathological 
diagnosis is dependent on similarities of the tumour cells to non-neoplastic 
mature glial cells. According to WHO classification, the three main types are 
astrocytomas, oligodendrogliomas, and mixed astrocytomas. Regardless of 
the histological cell types, gliomas are graded into low grade and high grade 
based on four main features: nuclear atypia, mitoses, microvascular 
proliferation and necrosis (Behin et al., 2003). 
 
Low grade tumours include grade I and II tumours, while high grade 
tumours include grade III and IV tumours. Specifically, grade I tumours are 
lesions with low proliferative potential and cure is possible following surgical 
resection. Grade II lesions encompass tumours that are infiltrative in nature, 
and despite having low proliferative activity, often recur. Some grade II 
tumours may undergo malignant transformation into higher grades of tumours, 
for instance low grade diffuse astrocytoma that transform into anaplastic 
astrocytoma or glioblastoma. Neoplasms designated grade III are lesions with 
histological features of malignancy, namely nuclear atypia and brisk mitotic 
activity. Patients with grade III tumours usually receive adjuvant radiotherapy 
and/or chemotherapy. Anaplastic astrocytomas (WHO grade III) account up to 
15% of malignant gliomas and the prognosis post-operation is about two 
years. Grade IV tumours are assigned when they are cytologically malignant, 
with active mitosis and necrosis, widespread infiltration of surrounding tissues 
as well as propensity for craniospinal spread (Louis et al., 2007). 
Glioblastoma multiforme represents most of the grade IV tumours, accounting 
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up to 52% of all gliomas. The peak incidence is at the fifth to sixth decades 
and the mortality is approaching 100% with the median survival of seven 
months (Hess et al., 2004). 
 
Despite histological diagnosis is the gold standard to diagnose gliomas, 
several studies have provided evidence of clinically significant interobserver 
variation on the typing and grading of gliomas. Erroneous classification and 
grading would lead to both undertreatment and overtreatment, as the 
treatment decisions and patient care are dependent upon the histological 
typing and grading. The occurrence of interobserver variation is largely due to 
technicalities, whereby the pathologists are not reviewing the exact same 
material due to sampling error, for which only very tiny fragments or a few 
slides were submitted. Another reason for the variation would be how the 
tumours are classified. Several subtypes of gliomas are being differentiated 
by their morphological appearance. The WHO classification utilises 
morphological description for the various histologies and grades, which 
contain subjective elements, for instance “moderately increased” cellularity for 
grade II astrocytoma and “increased” cellularity for grade III anaplastic 
astrocytoma. Due to the definitions, boundaries between grades and tumour 
types are subject to interpretation. More importantly, the dedifferentiation of 
low grade tumour into higher grade tumour is a gradual and continuous 
process, leading to artificial boundaries between grades. Tumour grades are 
not reflecting the real and existing different entities (van den Bent, 2010). 
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To date, apart from the histological diagnosis, molecular markers 
recently have been routinely acquired to aid in diagnosis and treatment 
guidance of gliomas. For instance, genetic loss on chromosomes 1p/19q is 
pathognomonic for oligodendroglioma and mutations of TP53 would suggest a 
astrocytic lineage.  Mutations of the isocitrate dehydrogenase gene (IDH) 1 or 
2 are characteristic of low grade gliomas. If they are found in high grade 
glioma, it would mean that the tumour has developed from a lower grade 
precursor lesion. These IDH-mutated tumours have more favourable 
prognosis (Stupp et al., 2014). Glioblastoma multiforme on the other hand 
would exhibit loss of genetic material on chromosome 10 and amplification of 
epidermal growth factor receptor (EGFR) in 72% and 38% of cases 
respectively (Andreas von Deimling et al., 1992). 
 
2.6 Treatment of Glioma 
 
The treatment of gliomas is highly individualised depending on the 
histological diagnosis and other factors, such as tumour grade, patient’s 
Karnofsky performance score to assess the daily functionality, neurological 
deficits and age (Schneider et al., 2010). Specialised multidisciplinary team 
involving neurosurgeons, medical and radiation oncologists, expert 
neuropathologist and neuroradiologist should be formed to evaluate individual 
patients and to provide the best treatment plan (Stupp et al., 2014). 
 
Management of glioma patients includes general management aim at 
symptomatic relief and specific management, which is definitive treatment, 
